Medicine supply notification: Clonidine (Catapres®) 100microgram tablets
These are out of stock until mid-Feb 2026. Clonidine 25microgram tablets and 50micrograms/5ml and 100micrograms/5ml sugar-free oral solution remain available and can support increased demand. If these are unsuitable, unlicensed supplies of 100microgram tablets may be sourced.
Source: Community Pharmacy England
Cardiovascular system disorders Neurological disorders
The 5mg and 10mg ampoules are out of stock, the 100mg ampoules are expected to become unavailable from early Jan, and the 30mg ampoules are unable to support increased demand. Morphine sulfate injection has been identified by clinical experts as the first-line alternative opioid.
Further Information
Source: Community Pharmacy England
Anaesthesia and pain
Hypurin® Porcine 30/70 mix 100units/ml suspension for injection 3ml cartridges will be out of stock until mid-January 2026. The remaining stock expired on 31 Dec 2025. The 10ml vials are being discontinued, but stock is available until Feb 2026 and can support increased demand.
Source: Community Pharmacy England
Diabetes
This product is out of stock until early Feb 2026. Latanoprost 50micrograms/ml / Timolol 5mg/ml (Vizilatan Duo®) preservative-free (PF) eye drops remain available and can support increased demand. Separate latanoprost and timolol PF topical eye presentations are also available.
Further Information
Source: Community Pharmacy England
Eyes and vision
Medicine supply notification: Nifedipine (Adipine® XL) 30mg and 60mg modified-release tablets
Nifedipine (Adipine® XL) 30mg and 60mg modified-release tablets are out of stock until the end of January 2026. Alternative brands of nifedipine 30mg and 60mg modified-release tablets remain available, but only some can support increased demand.
Further Information
Source: Community Pharmacy England
Cardiovascular system disorders
The reusable Pen device for these products will be out of stock from end Jan 2026 until at least early 2027. People whose battery life expires during this period will need switching to alternative device. Cartridges, GoQuick® pens and pre-filled disposable devices are available.
Source: Community Pharmacy England
Endocrine system disorders
| Ingredients | Product Name | Formulation | Report Category | Report Date |
| Nimodipine | Cerebonal Tablets (Nimodipine) | Film-coated tablet | Supply Discontinuation | 2026-01-05 |
| Nalbuphine Hydrochloride | Nalbuphine Hydrochloride Injection 10 Milligrams | Solution for Injection | Supply Discontinuation | 2026-01-05 |
| Active ingredients |
| Date of last message | Type of reason | AM designation | |
| Human fibrinogen | Change notification | 11.01.2026 | Other | FibCLOT | |
| Trimipramine mesylate | Change notification | 09.01.2026 | Other | Trimipramine – 1 A Pharma 40 mg/ml oral drops, solution | |
| Etoposide phosphate | Initial report | 09.01.2026 | Production problem | Etopophos 1000 mg, powder for solution for infusion | |
| Vandetanib | Initial report | 09.01.2026 | Other | Caprelsa 300 mg film-coated tablets – OP30 | |
| Phenobarbital sodium | Initial report | 09.01.2026 | Other | Luminal solution for injection | |
| Levetiracetam | Initial report | 09.01.2026 | Other | Keppra 100 mg/ml oral solution – OP (1x150ml) | |
| Morphine hemisulfate 2.5 hydrate | Initial report | 09.01.2026 | Production problem | Substitol 60 mg hard capsule, delayed release | |
| Erythromycin lactobionate | Initial report | 09.01.2026 | Production problem | Erythromycin Inresa i.v. 1g | |
| Lidocaine hydrochloride monohydrate | Change notification | 09.01.2026 | Other | Xylocaine Gel 2% | |
| Mometasone furoate (Ph.Eur.) | Initial report | 09.01.2026 | Production problem | Momecutan solution | |
| Insulin aspart | Initial report | 09.01.2026 | Other | NovoRapid 100 E/ml solution for injection in vial – OP[5x(1x10ml)] | |
| Pramipexole dihydrochloride monohydrate | Change notification | 09.01.2026 | Other | Pramipexole – 1 A Pharma 0.26 mg prolonged-release tablets | |
| Aprepitant | Change notification | 09.01.2026 | Other | EMEND 125 mg powder for oral suspension – OPXXXXmg | |
| Oxytocin | Change notification | 09.01.2026 | Production problem | Oxytocin 3 IU Hexal | |
| Metamizole sodium monohydrate | Change notification | 09.01.2026 | Production problem | Novaminsulfon – 1 A Pharma Drops | |
| Digoxin | Change notification | 08.01.2026 | Production problem | Lanicor | |
| Methylprednisolone | Change notification | 08.01.2026 | Production problem | Urbason 16 mg tablets | |
| (RS)-2,3-Bis(sulfanyl)propane-1-sulfonic acid sodium salt monohydrate | Initial report | 08.01.2026 | Production problem | Dimaval | |
| Epoetin theta | Initial report | 08.01.2026 | Other | Eporatio 5000 IU/0.5 ml injection solution in pre-filled syringe – OP (6×0.5 ml) | |
| Insulin aspart | Change notification | 08.01.2026 | Other | Kirsty 100 units/ml solution for injection in a pre-filled pen | |
| Insulin aspart | Change notification | 08.01.2026 | Other | Kirsty 100 units/ml solution for injection in a pre-filled pen | |
| Doxycycline monohydrate | Initial report | 08.01.2026 | Other | Doxycycline AL 200 | |
| Dinoprostone | Initial report | 08.01.2026 | Other | Prepidil Gel | |
| Fusidic acid (Ph.Eur.) | Change notification | 08.01.2026 | Production problem | Fucithalmic 10 mg/g eye drops | |
| Indomethacin | Initial report | 08.01.2026 | Other | Indomethacin AL 50 | |
| Oxycodone hydrochloride (Ph.Eur.) | Change notification | 08.01.2026 | Production problem | Oxygesic injection 10 mg/ml | |
| Lanreotide acetate (1:x) ((with information on acetic acid content)) | Change notification | 08.01.2026 | Production problem | Mytolac 120 mg solution for injection in a pre-filled syringe | |
| Lanreotide acetate (1:x) ((with information on acetic acid content)) | Change notification | 08.01.2026 | Production problem | Mytolac 90 mg solution for injection in a pre-filled syringe | |
| Risperidone | Change notification | 08.01.2026 | Production problem | Risperidone-ratiopharm 25 mg powder and solvent for the preparation of a prolonged-release injection suspension | |
| Risperidone | Change notification | 08.01.2026 | Production problem | Risperidone-ratiopharm 37.5 mg powder and solvent for the preparation of a prolonged-release injection suspension | |
| Risperidone | Change notification | 08.01.2026 | Production problem | Risperidone-ratiopharm 50 mg powder and solvent for the preparation of a depot injection suspension | |
| Sodium (methylprednisolone-21-succinate) | Change notification | 07.01.2026 | Other | Urbason solubile forte 1000 mg | |
| Paliperidone palmitate | Initial report | 07.01.2026 | Production problem | Paliperidone Advanz Pharma 150 mg depot injection suspension in a pre-filled syringe | |
| Paliperidone palmitate | Initial report | 07.01.2026 | Production problem | Paliperidone Advanz Pharma 100 mg Depot injection suspension in a pre-filled syringe | |
| Paliperidone palmitate | Change notification | 07.01.2026 | Production problem | Paliperidone Advanz Pharma 25 mg prolonged-release suspension for injection in a pre-filled syringe | |
| Paliperidone palmitate | Change notification | 07.01.2026 | Production problem | Paliperidone Advanz Pharma 50 mg prolonged-release suspension for injection in a pre-filled syringe | |
| Paliperidone palmitate | Change notification | 07.01.2026 | Production problem | Paliperidone Advanz Pharma 75 mg depot injection suspension in a pre-filled syringe | |
| Albendazole | Initial report | 07.01.2026 | Other | Eskazole | |
| Lamotrigine | Initial report | 07.01.2026 | Other | Lamictal 5 mg tablets for the preparation of an oral suspension or chewable tablets | |
| Disodium pamidronate | Initial report | 07.01.2026 | Production problem | PAMIDRO-cell 3 mg/ml concentrate for solution for infusion | |
| Biperiden hydrochloride | Change notification | 07.01.2026 | Production problem | Biperiden-neuraxpharm 4 mg | |
| Biperiden hydrochloride | Change notification | 07.01.2026 | Production problem | Biperiden-neuraxpharm 2 mg | |
| Galantamine hydrobromide | Change notification | 07.01.2026 | Other | Galantamine-neuraxpharm 8 mg hard capsules, delayed release | |
| Galantamine hydrobromide | Change notification | 07.01.2026 | Other | Galantamine-neuraxpharm 16 mg Hard capsules, delayed release | |
| Galantamine hydrobromide | Change notification | 07.01.2026 | Other | Galantamine-neuraxpharm 24 mg hard capsules, delayed release | |
| Cisatracurium besylate | Change notification | 07.01.2026 | Other | Nimbex 5mg | |
| Doxorubicin hydrochloride | Change notification | 07.01.2026 | Production problem | Doxorubicin hydrochloride Bendalis 2 mg/ml | |
| Fluorouracil | Change notification | 07.01.2026 | Other | Benda-5 FU | |
| Somatostatin acetate | Change notification | 07.01.2026 | Production problem | Somatostatin 3 mg Inresa | |
| Deferasirox | Change notification | 06.01.2026 | Other | Deferasirox Mylan 180 mg film-coated tablets | |
| Tenofovir disoproxil | Change notification | 06.01.2026 | Other | Tenofovir disoproxil Viatris 245 mg film-coated tablets – OP30 | |
| Tenofovir disoproxil | Change notification | 06.01.2026 | Other | Tenofovir disoproxil Mylan 245 mg film-coated tablets – OP90(3×30) | |
| Hydrochlorothiazide; Valsartan | Change notification | 06.01.2026 | Other | VALSARTAN COMP BASICS 160 mg/25 mg film-coated tablets | |
| Hydrochlorothiazide; Valsartan | Change notification | 06.01.2026 | Other | VALSARTAN COMP BASICS 80 mg/12.5 mg film-coated tablets | |
| Hydrochlorothiazide; Valsartan | Change notification | 06.01.2026 | Other | VALSARTAN COMP BASICS 160 mg/12.5 mg film-coated tablets | |
| Beclomethasone dipropionate (Ph.Eur.); formoterol fumarate dihydrate (Ph.Eur.); glycopyrronium bromide (Ph.Eur.) | Initial report | 06.01.2026 | Production problem | Trimbow 87 micrograms/5 micrograms/9 micrograms pressurized gas inhalation, solution – OP360 cans (3×120 cans) | |
| Aprepitant | Change notification | 05.01.2026 | Production problem | Aprepitant beta 125 mg and 80 mg hard capsules | |
| Atomoxetine hydrochloride | Change notification | 05.01.2026 | Production problem | Atomoxetine beta 80 mg hard capsules | |
| Aprepitant | Change notification | 05.01.2026 | Production problem | Aprepitant beta 80 mg hard capsules | |
| Fluoxetine hydrochloride | Change notification | 05.01.2026 | Other | Fluoxetine beta 20 | |
| Penicillamine | Change notification | 05.01.2026 | Production problem | Metalcaptase 150 mg | |
| Iron(III) hexacyanoferrate(II) | Change notification | 05.01.2026 | Other | Thallium antidote | |
| Rivastigmine hydrogen tartrate | Change notification | 05.01.2026 | Production problem | Rivastigmine Aurobindo 6 mg hard capsules | |
| Insulin lispro | Initial report | 05.01.2026 | Other | Liprolog 200 units/ml solution for injection in pre-filled pen – OP[2x(5x3ml)] | |
| Hydromorphone hydrochloride | Change notification | 05.01.2026 | Other | Hydromorphone HCl PUREN 4 mg hard capsules, delayed release | |
| Escitalopram oxalate | Change notification | 05.01.2026 | Other | Escitalopram Aurobindo 10 mg film-coated tablets | |
| Flucloxacillin sodium 1 H<2>O | Change notification | 05.01.2026 | Production problem | Staphylex 250 mg capsules | |
| Moxifloxacin hydrochloride (Ph.Eur.) ((with information on water content (1:x))) | Change notification | 05.01.2026 | Other | Moxifloxacin Holsten 400 mg film-coated tablets | |
| Insulin lispro | Initial report | 05.01.2026 | Other | Liprolog 100 E/ml KwikPen solution for injection – OP[2x(5x3ml)] | |
| Clomipramine hydrochloride | Change notification | 05.01.2026 | Production problem | Anafranil 75mg retard | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 05.01.2026 | Other | Seroquel Prolong 150 mg prolonged-release tablets | |
| Amlodipine besylate; Perindopril tert-butylamine | Change notification | 05.01.2026 | Production problem | Perindopril/amlodipine Denk 8 mg/5 mg tablets | |
| Gentamicin sulfate | Change notification | 05.01.2026 | Production problem | Gentamicin-POS | |
| Phenylephrine hydrochloride | Change notification | 05.01.2026 | Production problem | Neosynephrine-POS 5% | |
| Minocycline hydrochloride dihydrate (Ph.Eur.) | Change notification | 05.01.2026 | Production problem | Skid 50 mg | |
| Minocycline hydrochloride dihydrate (Ph.Eur.) | Change notification | 05.01.2026 | Production problem | Skid 100 mg | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 05.01.2026 | Other | Quetiapine Hormosan 300 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 05.01.2026 | Other | Quetiapine Hormosan 400 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 05.01.2026 | Other | Quetiapine-Hormosan 200 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 05.01.2026 | Other | Quetiapine-Hormosan 150 mg prolonged-release tablets | |
| Oxycodone hydrochloride (Ph.Eur.) | Change notification | 05.01.2026 | Other | Oxycan uno 10 mg prolonged-release tablets |
| Active ingredients | Status | Update | Specialty |
| alfacalcidol | Stock shortage | 09/01/2026 | Un-Alfa 1 microgram/0.5 ml, IV injectable solution in ampoule |
| methylphenidate (hydrochloride) | Supply tension | 09/01/2026 | Viatris LP Methylphenidate Extended-Release Tablet |
| propranolol hydrochloride | Supply tension | 09/01/2026 | Propranolol-based specialties 40 mg, tablet |
| interferon gamma-1b | Stock shortage | 08/01/2026 | Imukin 2 X 10p6 IU (0.1 mg), injectable solution |
| baclofen | Return to availability | 08/01/2026 | Baclofen Zentiva 10 mg, breakable tablet |
| gemcitabine (hydrochloride) | Stock shortage | 07/01/2026 | Gemcitabine Sun 10 mg/mL, solution for infusion in 120 mL bag |
| fluorouracil | Return to availability | 07/01/2026 | Fluorouracil Accord 50 mg/mL, solution for dilution for infusion, 5 mL, 20 mL, and 100 mL vials |
| methylphenidate (hydrochloride) | Return to availability | 07/01/2026 | Biogaran Methylphenidate, extended-release tablet |
| Varicella-Zoster Virus (VZV) glycoprotein E antigen (recombinant, with adjuvant) ((mammalian/hamster/CHO cells)) | Return to availability | 07/01/2026 | Shingrix, powder and suspension for suspension for injection. Shingles vaccine (recombinant, with adjuvant) |
| risperidone | Stock shortage | 07/01/2026 | Risperidone L.P. 25 mg/2 mL, 37.5 mg/2 mL, and 50 mg/2 mL, powder and solvent for extended-release suspension for injection in a pre-filled syringe |
| risperidone | Return to availability | 07/01/2026 | RisperdalConsta L.P. 25 mg/2 mL, 37.5 mg/2 mL, and 50 mg/2 mL powder and solvent for extended-release suspension for injection in a pre-filled syringe |
| febuxostat hemihydrate | Supply tension | 07/01/2026 | Febuxostat 80 mg, film-coated tablet |
| valproic acid, sodium (valproate) | Supply tension | 06/01/2026 | Micropakine L.P., extended-release granules in single-dose sachets |
| atropine (sulfate) | Marketing discontinuation | 06/01/2026 | Atropine 0,3%, collyre |
| hydroxocobalamin | Supply tension | 05/01/2026 | Cyanokit 5 g, powder for solution for infusion |
| human von Willebrand factor | Supply tension | 05/01/2026 | Wilfactin 100 IU/mL, powder and solvent for solution for injection |
| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| lidocaine hydrochloride | Injection, concentrated | 100 mg/mL | Anticipated | Available | Manufacturing | 9/01/2026 |
| trandolapril | Capsule | 4 mg | Current | Limited Availability | Manufacturing | 9/01/2026 |
| isoniazid | Tablet, uncoated | 100 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| valsartan~hydrochlorothiazide | Tablet, film coated | 160 mg~12.5 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| temozolomide | Capsule, hard | 20 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| simvastatin~ezetimibe | Tablet | 40 mg~10 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| raloxifene hydrochloride | Tablet, film coated | 60 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| clindamycin hydrochloride | Capsule, hard | 162.87 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| clindamycin hydrochloride | Capsule, hard | 162.87 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| dulaglutide | Injection, solution | 1.5 mg | Resolved | Available | Manufacturing | 9/01/2026 |
| methylphenidate hydrochloride | Capsule, modified release | 60 mg | Current | Limited Availability | Manufacturing | 9/01/2026 |
| tenofovir disoproxil fumarate~emtricitabine | Tablet, film coated | 300 mg~200 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| ambrisentan | Tablet, film coated | 10 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| ambrisentan | Tablet, film coated | 5 mg | Current | Limited Availability | Manufacturing | 9/01/2026 |
| hydrochlorothiazide~olmesartan medoxomil | Tablet | 12.5 mg~40 mg | Current | Unavailable | Manufacturing | 9/01/2026 |
| bimatoprost | Eye Drops | .3 mg/mL | Current | Limited Availability | Manufacturing | 9/01/2026 |
| dabigatran etexilate mesilate | Capsule, hard | 172.95 mg | Current | Unavailable | Manufacturing | 9/01/2026 |
| paroxetine hydrochloride | Tablet, film coated | 22.22 mg | Current | Unavailable | Manufacturing | 9/01/2026 |
| Adalimumab | Injection, solution | 20 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 9/01/2026 |
| gliclazide | Tablet, uncoated | 80 mg | Anticipated | Available | Manufacturing | 9/01/2026 |
| estradiol | Drug delivery system, transdermal | .585 mg | Current | Unavailable | Manufacturing | 9/01/2026 |
| lamotrigine | Tablet, chewable | 100 mg | Resolved | Available | Manufacturing | 9/01/2026 |
| lamotrigine | Tablet, chewable | 200 mg | Current | Unavailable | Manufacturing | 9/01/2026 |
| nitrofurantoin | Capsule, hard | 100 mg | Resolved | Available | Unexpected increase in consumer demand | 9/01/2026 |
| isotretinoin | Capsule, soft | 10 mg | Current | Unavailable | Manufacturing | 9/01/2026 |
| mupirocin | Ointment | 20 mg/g | Resolved | Available | Manufacturing | 9/01/2026 |
| levodopa~carbidopa monohydrate | Tablet, uncoated | 100 mg~26.9 mg | Current | Limited Availability | Manufacturing | 9/01/2026 |
| pioglitazone hydrochloride | Tablet, uncoated | 16.53 mg | Current | Unavailable | Manufacturing | 9/01/2026 |
| pioglitazone hydrochloride | Tablet, uncoated | 33.06 mg | Current | Unavailable | Manufacturing | 9/01/2026 |
| pioglitazone hydrochloride | Tablet, uncoated | 49.59 mg | Current | Unavailable | Manufacturing | 9/01/2026 |
| methylphenidate hydrochloride | Capsule, modified release | 20 mg | Current | Limited Availability | Manufacturing | 9/01/2026 |
| methylphenidate hydrochloride | Capsule, modified release | 40 mg | Current | Limited Availability | Manufacturing | 9/01/2026 |
| rifampicin | Oral Liquid | 20 mg/mL | Anticipated | Available | Unexpected increase in consumer demand | 8/01/2026 |
| baclofen | Tablet, uncoated | 10 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 8/01/2026 |
| trandolapril | Capsule | 2 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 8/01/2026 |
| ciprofloxacin hydrochloride | Tablet, film coated | 555 mg | Current | Limited Availability | Manufacturing | 8/01/2026 |
| nortriptyline | Tablet, film coated | 10 mg | Anticipated | Available | Manufacturing | 8/01/2026 |
| lamotrigine | Tablet, chewable | 100 mg | Resolved | Available | Manufacturing | 8/01/2026 |
| finasteride | Tablet, film coated | 1 mg | Anticipated | Available | Unexpected increase in consumer demand | 8/01/2026 |
| galantamine hydrobromide | Capsule, modified release | 20.512 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 8/01/2026 |
| galantamine hydrobromide | Capsule, modified release | 30.768 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 8/01/2026 |
| bisoprolol fumarate | Tablet | 2.5 mg | Resolved | Available | Manufacturing | 8/01/2026 |
| bisoprolol fumarate | Tablet | 10 mg | Resolved | Available | Manufacturing | 8/01/2026 |
| levetiracetam | Tablet, film coated | 500 mg | Current | Limited Availability | Manufacturing | 8/01/2026 |
| rocuronium bromide | Injection, solution | 50 mg | Current | Limited Availability | Manufacturing | 8/01/2026 |
| pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Current | Unavailable | Manufacturing | 8/01/2026 |
| pramipexole dihydrochloride monohydrate | Tablet | 1 mg | Current | Unavailable | Manufacturing | 8/01/2026 |
| exemestane | Tablet, sugar coated | 25 mg | Resolved | Available | Manufacturing | 8/01/2026 |
| galantamine hydrobromide | Capsule, modified release | 10.252 mg | Current | Unavailable | Manufacturing | 8/01/2026 |
| galantamine hydrobromide | Capsule, modified release | 30.756 mg | Current | Unavailable | Manufacturing | 8/01/2026 |
| galantamine hydrobromide | Capsule, modified release | 20.504 mg | Current | Unavailable | Manufacturing | 8/01/2026 |
| mirtazapine | Tablet, orally disintegrating | 15 mg | Anticipated | Available | Manufacturing | 8/01/2026 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Anticipated | Available | Manufacturing | 8/01/2026 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Current | Unavailable | Manufacturing | 8/01/2026 |
| enalapril maleate | Tablet | 5 mg | Current | Unavailable | Manufacturing | 8/01/2026 |
| enalapril maleate | Tablet | 5 mg | Resolved | Available | Manufacturing | 8/01/2026 |
| quetiapine fumarate | Tablet, modified release | 230.26 mg | Resolved | Available | Manufacturing | 8/01/2026 |
| GluureaLys(ahx)hbedCC | Injection, powder for | 25 microgram | Resolved | Available | Manufacturing | 8/01/2026 |
| GluureaLys(ahx)hbedCC | Injection, powder for | 25 microgram | Resolved | Available | Manufacturing | 8/01/2026 |
| mitomycin | Injection, powder for | 20 mg | Current | Limited Availability | Manufacturing | 8/01/2026 |
| isoprenaline hydrochloride | Injection, solution | 1 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 8/01/2026 |
| diltiazem hydrochloride | Capsule, modified release | 180 mg | Current | Limited Availability | Manufacturing | 8/01/2026 |
| diltiazem hydrochloride | Capsule, modified release | 360 mg | Current | Limited Availability | Manufacturing | 8/01/2026 |
| ciprofloxacin hydrochloride | Tablet, film coated | 582.21 mg | Current | Limited Availability | Manufacturing | 8/01/2026 |
| nizatidine | Capsule, hard | 300 mg | Resolved | Available | Manufacturing | 8/01/2026 |
| galantamine hydrobromide~galantamine | Capsule, modified release | 10.25 mg~8 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 8/01/2026 |
| galantamine hydrobromide~galantamine | Capsule, modified release | 20.51 mg~16 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 8/01/2026 |
| galantamine hydrobromide~galantamine | Capsule, modified release | 30.76 mg~24 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 8/01/2026 |
| bethanechol chloride | Tablet, uncoated | 10 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 7/01/2026 |
| galantamine hydrobromide | Capsule, modified release | 30.756 mg | Current | Unavailable | Manufacturing | 7/01/2026 |
| cyproterone acetate | Tablet, uncoated | 100 mg | Anticipated | Available | Manufacturing | 7/01/2026 |
| paclitaxel | Injection, powder for | 100 mg | Anticipated | Available | Manufacturing | 7/01/2026 |
| cabazitaxel | Injection, concentrated | 60 mg | Current | Limited Availability | Manufacturing | 7/01/2026 |
| rimegepant sulfate | Tablet, orally disintegrating | 85.65 mg | Anticipated | Available | Manufacturing | 7/01/2026 |
| stannous chloride dihydrate | Injection, powder for | 19.2 microgram/mL | Current | Unavailable | Manufacturing | 7/01/2026 |
| ropivacaine hydrochloride | Injection, solution | 10 mg/mL | Anticipated | Available | Manufacturing | 7/01/2026 |
| desferrioxamine mesilate | Injection, powder for | 2 g | Current | Limited Availability | Manufacturing | 7/01/2026 |
| etoposide phosphate | Injection, powder for | 1136 mg | Current | Limited Availability | Manufacturing | 7/01/2026 |
| cyproterone acetate | Tablet, uncoated | 50 mg | Resolved | Available | Unexpected increase in consumer demand | 6/01/2026 |
| diclofenac potassium | Oral Liquid, powder for | 50 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 6/01/2026 |
| tranexamic acid | Tablet, film coated | 500 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 6/01/2026 |
| calcium folinate hydrate | Tablet, uncoated | 18.6 mg | Anticipated | Available | Unexpected increase in consumer demand | 6/01/2026 |
| galantamine hydrobromide | Capsule, modified release | 10.252 mg | Current | Unavailable | Manufacturing | 6/01/2026 |
| galantamine hydrobromide | Capsule, modified release | 20.504 mg | Current | Unavailable | Manufacturing | 6/01/2026 |
| montelukast sodium | Tablet | 10.4 mg | Anticipated | Available | Commercial Changes / Commercial viability | 6/01/2026 |
| pemetrexed disodium | Injection, powder for | 1102.9 mg | Current | Unavailable | Manufacturing | 6/01/2026 |
| Pegvisomant | Injection, powder for | 10 mg | Resolved | Available | Manufacturing | 6/01/2026 |
| topotecan hydrochloride | Injection, concentrated | 4.346 mg | Current | Limited Availability | Unexpected increase in consumer demand | 6/01/2026 |
| clonidine hydrochloride | Tablet, uncoated | 150 microgram | Current | Unavailable | Manufacturing | 6/01/2026 |
| live varicella vaccine | Injection, powder for | 2700 PFU/mL | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 5/01/2026 |
| risperidone | Tablet | 1 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 5/01/2026 |
| cyproterone acetate | Tablet, uncoated | 50 mg | Current | Limited Availability | Manufacturing | 5/01/2026 |
| iopromide | Injection, solution | 498.72 mg/mL | Resolved | Available | Manufacturing | 5/01/2026 |
| ropivacaine hydrochloride | Injection, solution | 2 mg/mL | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 5/01/2026 |
| ropivacaine hydrochloride | Injection, solution | 7.5 mg/mL | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 5/01/2026 |
| pemetrexed disodium | Injection, powder for | 551.4 mg | Current | Limited Availability | Manufacturing | 5/01/2026 |
| linezolid | Tablet, film coated | 600 mg | Current | Unavailable | Manufacturing | 5/01/2026 |
| olmesartan medoxomil~hydrochlorothiazide | Tablet | 40 mg~12.5 mg | Current | Unavailable | Manufacturing | 5/01/2026 |
| sildenafil citrate | Tablet, film coated | 70.24 mg | Current | Unavailable | Commercial Changes / Commercial viability | 5/01/2026 |
| prilocaine hydrochloride | Injection, solution | 100 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 5/01/2026 |
| cefalexin monohydrate | Capsule, hard | 250 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 5/01/2026 |
| Generic Name | Shortage Status | Revision Date |
| Leucovorin Calcium Tablets | Current Shortages | 8-Jan-26 |
| Mometasone Furoate Aerosol for Oral Inhalation | Current Shortages | 8-Jan-26 |
| Mometasone Furoate and Formoterol Fumarate Inhalation Aerosol | Current Shortages | 8-Jan-26 |
| Azithromycin Injection | Current Shortages | 7-Jan-26 |
| Oseltamivir Oral Suspension and Capsules | Current Shortages | 7-Jan-26 |
| Magnesium Sulfate Injection | Current Shortages | 6-Jan-26 |
| Megestrol Acetate Tablets | Current Shortages | 6-Jan-26 |
| Phenytoin Oral Suspension | Resolved Shortages | 6-Jan-26 |
| Ropivacaine Injection | Current Shortages | 6-Jan-26 |
| Ketamine Injection | Current Shortages | 5-Jan-26 |
| Linezolid Injection | Current Shortages | 5-Jan-26 |
| Methotrexate Injection | Current Shortages | 5-Jan-26 |
| Metoprolol Injection | Current Shortages | 5-Jan-26 |
| Pantoprazole Injection | Current Shortages | 5-Jan-26 |
| Theophylline 24-Hour Extended Release Capsules and Tablets | Current Shortages | 5-Jan-26 |
